Literature DB >> 10947876

The role of habitual snoring and obesity in the development of diabetes: a 10-year follow-up study in a male population.

A Elmasry1, C Janson, E Lindberg, T Gislason, M A Tageldin, G Boman.   

Abstract

OBJECTIVES: There are many similarities between diabetes (mainly type 2) and sleep breathing disturbances regarding risk factors, anthropometric criteria and consequences of morbidity and mortality. The aim of this study was to investigate whether the association between habitual snoring and diabetes is entirely dependent on obesity.
DESIGN: A population-based prospective study.
SETTING: The municipality of Uppsala, Sweden. SUBJECTS AND METHODS: In 1984 and in 1994, 2668 men aged 30-69 years at baseline answered questionnaires concerning sleep breathing disturbances and somatic diseases.
RESULTS: Of those with habitual snoring in 1984, 5.4% reported that they had developed diabetes during the 10-year period compared with 2.4% of those without habitual snoring (P < 0.001). Amongst obese snorers, 13.5% developed diabetes compared with 8.6% of obese non-snorers (P = 0.17). In a multiple logistic regression model, the odds ratio (95% confidence interval) for development of diabetes was higher in obese snorers [7.0 (2.9-16.9)] than in obese non-snorers [5.1 (2.7-9.5)] after adjustment for age, weight gain, smoking, alcohol dependence and physical inactivity.
CONCLUSIONS: We conclude that, in males aged 30-69 years, habitual snoring is associated with an increased incidence of diabetes within 10 years. Although obesity is the main risk factor for developing diabetes, coexistent habitual snoring may add to this hazard.

Entities:  

Mesh:

Year:  2000        PMID: 10947876     DOI: 10.1046/j.1365-2796.2000.00683.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  50 in total

1.  Follow-up on metabolic markers in children treated for obstructive sleep apnea.

Authors:  Karen A Waters; Sinthu Sitha; Louise M O'brien; Sherryn Bibby; Carina de Torres; Silvano Vella; Roland de la Eva
Journal:  Am J Respir Crit Care Med       Date:  2006-05-18       Impact factor: 21.405

2.  Self-reported snoring and metabolic syndrome: the Korean Multi-Rural Communities Cohort Study.

Authors:  Min-Ho Shin; Sun-Seog Kweon; Bo Youl Choi; Mi Kyung Kim; Byung-Yeol Chun; Dong Hoon Shin; Young-Hoon Lee
Journal:  Sleep Breath       Date:  2013-11-06       Impact factor: 2.816

3.  Sleep Apnea and Metabolic Dysfunction: Cause or Co-Relation?

Authors:  R Nisha Aurora; Naresh M Punjabi
Journal:  Sleep Med Clin       Date:  2007-06-01

4.  Sleep and Glucose Intolerance/Diabetes Mellitus.

Authors:  Mary Ip; Babak Mokhlesi
Journal:  Sleep Med Clin       Date:  2007

5.  Sleep Apnea and its association with the Stress System, Inflammation, Insulin Resistance and Visceral Obesity.

Authors:  G Trakada; G Chrousos; S Pejovic; A Vgontzas
Journal:  Sleep Med Clin       Date:  2007-06

Review 6.  Obstructive sleep apnea is a common disorder in the population-a review on the epidemiology of sleep apnea.

Authors:  Karl A Franklin; Eva Lindberg
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

Review 7.  Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea.

Authors:  Brian D Kent; Walter T McNicholas; Silke Ryan
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

8.  Obstructive sleep apnea as a risk factor for type 2 diabetes.

Authors:  Nader Botros; John Concato; Vahid Mohsenin; Bernardo Selim; Kervin Doctor; Henry Klar Yaggi
Journal:  Am J Med       Date:  2009-12       Impact factor: 4.965

9.  Prevalence of type 2 diabetes in patients with obstructive sleep apnea in a multi-ethnic sample.

Authors:  Kamran Mahmood; Natasha Akhter; Kamal Eldeirawi; Ergün Onal; John W Christman; David W Carley; James J Herdegen
Journal:  J Clin Sleep Med       Date:  2009-06-15       Impact factor: 4.062

10.  Sleep and metabolism: an overview.

Authors:  Sunil Sharma; Mani Kavuru
Journal:  Int J Endocrinol       Date:  2010-08-02       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.